 Regeneron Pharmaceuticals Inc. REGN, -0.88 announced Thursday an agreement in which it will pay up to 1.1 billion plus royalties for Sanofi S.A.s SNY, -0.08 stake in the Regeneron-Sanofi collaboration on cancer treatment Libtayo. 